CYTOPOINT® − Home

Cytopoint Professional Home Page Hero Image

For dogs with atopic dermatitis, CYTOPOINT^® offers a full month of relief with a single in-clinic injection¹, helping to improve the quality of life for dogs and their families

TARGETED

Targets and neutralises interleukin (IL)-31, a key itch-inducing cytokine in atopic dermatitis²

WORKS FAST AND LASTS

Begins working within 8 hours and delivers a full month of relief* from the clinical signs of atopic dermatitis¹; in-clinic administration ensures compliance

FLEXIBLE

Can be used in dogs of all ages, even those with concomitant disease as well as alongside many common medications¹

Indication: CYTOPOINT treats clinical manifestations of atopic dermatitis in dogs.

Repeat administration monthly as needed in the individual patient.

References: 1. CYTOPOINT Summary of Product Characteristics 2. Gonzales AJ, Humphrey WR, Messamore JE, et al. Interleukin-31: its role in canine pruritus and naturally occurring canine atopic dermatitis. Vet Dermatol. 2013;24(1):48-53. doi:10.1111/j.1365-3164.2012.01098.x.

The material contained within this website is intended to be viewed by practising veterinary surgeons in Ireland only. The drugs listed in this website may have different technical specifications approved in other countries.